← All trials
NCT00981981
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2008
- Primary completion
- Jul 1, 2009
- Completion date
- Aug 1, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- 367
- Arms / groups
- 5 / —
- Source
- AACT · pre-existing
Sponsors
- Glycemic Index Laboratories, IncLead sponsor
- University of GuelphCollaborator
- University of SydneyCollaborator
- Laval UniversityCollaborator
- University of TorontoCollaborator
- Glycemic Index Laboratories, IncOverall official - principal investigator
- Agriculture and Agri-Food CanadaStudy director
- University of TorontoStudy director
- Reading Scientific Services Ltd.Collaborator
- Agriculture and Agri-Food CanadaCollaborator
- Naturex SACollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.